Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$8.56 5.03%
Market Cap
$453.3M
Price Target
Refer to Report
Volume
560.8K
52wk Range
$1.34 - $8.97
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.